Healthcare >> Analyst Interviews >> December 6, 1999
MICHAEL G. KING, JR. is a Managing Director and Senior Biotechnology
Analyst at Robertson Stephens. He focuses on the genomics sector. Prior
to joining Robertson Stephens he was a Senior Biotechnology Analyst at
Vector Securities International and served as Vice President of
Research, Biotechnology, with Dillon, Read & Co., Inc. Mr. King also has
been a Senior Vice President of Sales at Alex. Brown and Sons. In 2001,
he ranked fourth for his stock-picking accuracy in The Wall Street
Journal's annual 'Best on the Street' survey. In 2000, Mr. King was
given the Institutional Investor Home Run Hitter award for his coverage
of OSI Pharmaceuticals. He holds a BBA degree from Baruch College. Profile
Mr. King: We cover a variety of different industries, including
traditional biotherapeutics companies as well as companies in the tools
space. These
